Rydapt Rydapt

Rydapt Rydapt

Dosage Form:AML: 50 mg orally twice daily with food. ASM, SM-AHN, and MCL: 100 mg orally twice daily with food. 

Side Effect:AML: The most common adverse reactions (≥ 20%) were febrile Initial U.S. Approval: 2017 neutropenia, nausea, mucositis, vomiting, headache, petechiae, musculoskeletal pain, epistaxis, device-related infection, hyperglycemia, and upper respiratory tract infection.  • ASM, SM-AHN, or MCL: The most common adverse reactions (≥ 20%) with: were nausea, vomiting, diarrhea, edema, musculoskeletal pain, abdominal • Newly diagnosed acute myeloid leukemia (AML) that is FLT3 mutation- pain, fatigue, upper respiratory tract infection, constipation, pyrexia, positive as detected by an FDA-approved test, in combination with headache, and dyspnea

其他药品

预约跨境治疗服务
请留下您的联系方式,我们将第一时间与你取得联系
选择预约类型
Phone全国服务热线 400-076-3808
爱医传递